StemRIM

2026/10/09 19:27 Updated
Market Cap: $65.1M (¥10.3B)
Stock Price: $1.04 (¥164)
Exchange Rate: 1 USD = ¥157.98

Notice of Patent Registration (Australia) for Regenesis-Inducing Drug Redasemtide (HMGB1 Fragment Peptide) for Chondral Disorders

Importance:
Page Updated: September 21, 2026
IR Disclosure Date: June 17, 2026
Other

StemRIM

Company overview · Stock price · Financial data · All IR

View company page →